Skip to content

Carter Bankshares

US · CARE #3513 by market cap
30.19 -0.27 -0.89%
Live - 5344 symbols - heartbeat 514s ago · 2026-10-08 07:33
Pre-market 29.81 -1.27%
After-hours 30.19 0.00%
Market cap
699.32M
P/B
1.30
EPS
1.38
Reader sentiment Are you bullish or bearish on CARE?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Above fair value
8.29 fair value ≈ 18.45 28.60
  • Implied fair-value range of 8.29-28.60, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +63.7% above the average-multiple fair value of 18.45.

Valuation each multiple against its own 5-year range

P/B ratio 1.30 Expensive vs history 91st percentile
5-year average 1.06 · #235 of 354 in Banks - Regional
P/E ratio 5.21 Cheap vs history 3rd percentile
5-year average 13.37 · forward 13.73 · #2 of 305 in Banks - Regional
P/S ratio 3.26 Expensive vs history 88th percentile
5-year average 2.77 · forward 3.73 · #162 of 354 in Banks - Regional

Vs. peers Banks - Regional

Company Market cap P/E (TTM) P/B Div yield
Carter Bankshares (CARE) 699.32M 5.21 1.30 0.33%
Mizuho Financial (MFG) 131.05B 16.93 1.83 1.62%
HDFC Bank (HDB) 113.60B 15.61 1.35 1.60%
Itau Unibanco (ITUB) 107.35B 11.64 2.47 6.15%
ICICI Bank (IBN) 100.00B 18.03 2.66 0.83%
U.S. Bancorp (USB) 87.52B 11.21 1.44 3.70%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value29.05 Economic moatNone UncertaintyHigh

Trading 3.8% above Morningstar's fair value estimate.

Fair value

Carter Bankshares Inc is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 4% premium over our quantitative fair value estimate of $29.05 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The company's lack of profitability weakens our estimated valuation. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. For example, the firm's sales yield of 31.7% lies in the bottom 40% compared with peers globally. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which contributes to our view that shares are overvalued.

On a different note, the firm's valuation metrics are reassuring. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 79.1%, a core component of valuation, lies in the top 40% globally. The market price is low relative to the book (accounting) value of the company's equity, which, despite our unfavorable price/fair value ratio, is a positive attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.

By Quantitative Equity Report

Quote time 2026-10-08 07:33:31 · For reference only, not investment advice and not tailored to your situation.